COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful
Éric Farfour(European Foundation for Clinical Nanomedicine), Marc Vasse(Hôpital Foch), Charles Cerf(Hôpital Foch), Richard Galliot(Hôpital Foch), Sylvie Colin de Verdière(Université de Versailles Saint-Quentin-en-Yvelines), C. Picard(Hôpital Foch), Félix Ackermann(Hôpital Foch), Philippe Lesprit(Hôpital Foch), Marie‐Christine Ballester(Hôpital Foch), L. Beaumont(Hôpital Foch)
Cited by 17
Related Papers
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study
|The Lancet Respiratory Medicine|2021|257
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure
|JAMA Internal Medicine|2022|151
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140